Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -259,622 | -213,555 | -41,100 | -22,680 | -138,375 |
| Depreciation Amortization | 59,761 | 198,816 | 29,784 | 14,493 | 51,710 |
| Income taxes - deferred | 11 | N/A | N/A | N/A | 754,942 |
| Accounts receivable | 14,359 | 25,789 | 19,771 | 17,883 | 84,395 |
| Accounts payable and accrued liabilities | 723 | -1,531 | 889 | -3,682 | 5,284 |
| Other Working Capital | -12,614 | -2,172 | -4,471 | -10,641 | 97,844 |
| Other Operating Activity | 204,847 | 14,756 | 4,094 | -3,840 | -729,576 |
| Operating Cash Flow | $7,465 | $22,103 | $8,967 | $-8,467 | $126,224 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29,658 | -23,809 | -15,218 | -5,665 | -65,553 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -69,622 |
| Purchase Of Investment | N/A | -1,000 | N/A | N/A | N/A |
| Other Investing Activity | 5,342 | 5,424 | 4,792 | 1,421 | 12,865 |
| Investing Cash Flow | $-24,316 | $-19,385 | $-10,426 | $-4,244 | $-122,310 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -234,393 | -4,533 | -3,013 | -1,505 | -5,440 |
| Other Financing Activity | -1,319 | 5,010 | 2,681 | 945 | -55,650 |
| Financing Cash Flow | $-235,712 | $477 | $-332 | $-560 | $-61,090 |
| Beginning Cash Position | 574,962 | 574,962 | 574,962 | 574,962 | 632,138 |
| End Cash Position | 322,399 | 578,157 | 573,171 | 561,691 | 574,962 |
| Net Cash Flow | $-252,563 | $3,195 | $-1,791 | $-13,271 | $-57,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,465 | 22,103 | 8,967 | -8,467 | 126,224 |
| Capital Expenditure | -29,658 | -23,809 | -15,218 | -5,665 | -65,553 |
| Free Cash Flow | -22,193 | -1,706 | -6,251 | -14,132 | 60,671 |